机构名称：
¥ 1.0
On September 19, 2024, GC Therapeutics (GCTx), a biopharmaceutical company created to scale and unlock the next generation of cell therapy-based medicines, launched and announced the successful completion of a $65 million Series A financing led by Cormorant Asset Management with participation from Mubadala Capital, Andreessen Horowitz (a16z) Bio + Health, Medical Excellence Capital, Cercano Management, and Pear VC，将GCTX筹集的总资本提高到7500万美元。Wilson Sonsini Goodrich＆Rosati就交易建议GC Therapeutics。Wilson Sonsini Goodrich＆Rosati就交易建议GC Therapeutics。
Wilson-Sonsini-Advises-GC-Therapeutics-On- 6500万美元...
主要关键词
相关文件推荐
